News
The past year has witnessed the formation of several collaborations between ophthalmic start-ups and institutions or groups that traditionally haven’t been involved in developing medical…
Read More
Recent positive reports about two FDA-approved corneal inlays may yet give this market sector a boost heading into 2017. Irvine, CA-based AcuFocus was the first…
Read More
At last month’s OIS@AAO, we introduced the OIS Index. To learn more about its origins and intent, listen to this OIS Podcast interview. By Michael…
Read More
Sustained-Release Eylea Focus of Collaboration Ocular Therapeutix Inc. and Regeneron entered into a collaboration agreement to develop a sustained-release formulation of Regeneron’s Eylea (aflibercept), currently…
Read More
Update on Topcon-IBM Watson Health Collaboration Selected to participate in IBM’s Watson Health medical imaging collaborative, Topcon has divulged few specifics, but at the AAO…
Read More
OIS Co-Chair Emmett T. Cunningham Jr., MD, PhD, MPH laid out hopeful – and cautionary – signs facing the ophthalmology industry as he kicked off…
Read More
More than 800 leaders of the ophthalmology industry will convene Thursday at the Hyatt Regency Chicago Hotel ballroom for our largest Ophthalmology Innovation Summit of…
Read More
Now that Regeneron has announced that its rinucumab-Eylea (aflibercept) combination treatment for wet age-related macular degeneration (AMD) failed to meet the primary endpoint of a…
Read More
Johnson & Johnson Moves to Buy AMO The evolution of the ophthalmology sector continued with this month’s news that Johnson & Johnson Vision Care would…
Read More
Earlier this month, Aerie Pharmaceuticals filed its first NDA for once-daily Rhopressa (netarsudil) and released top-line data from its once-daily Roclatan (Rhopressa and latanoprost) Mercury…
Read More
The evolution of the ophthalmology sector continued with last week’s news that Johnson & Johnson would pay $4.3 billion to acquire Abbott Medical Optics, the…
Read More
The ophthalmology sector last week descended upon Copenhagen, which hosted three sizable clinical meetings including ESCRS, EuRetina, and EuCornea. Several companies used the convergence to…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")